NO983464L - Buffersystemer for stabilisering av farmas°ytiske preparater - Google Patents
Buffersystemer for stabilisering av farmas°ytiske preparaterInfo
- Publication number
- NO983464L NO983464L NO983464A NO983464A NO983464L NO 983464 L NO983464 L NO 983464L NO 983464 A NO983464 A NO 983464A NO 983464 A NO983464 A NO 983464A NO 983464 L NO983464 L NO 983464L
- Authority
- NO
- Norway
- Prior art keywords
- buffer systems
- pharmaceutical preparations
- stabilizing pharmaceutical
- stabilizing
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Den foreliggende patentsøknad vedrører nye buffersystemer, bestående av et fysiologisk akseptabelt amin og en karboksylsyre, for fremstilling av farmasøytiske midler.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19604230 | 1996-01-29 | ||
PCT/DE1996/002488 WO1997028104A2 (de) | 1996-01-29 | 1996-12-20 | Puffersysteme zur stabilisierung pharmazeutischer zubereitungen |
Publications (2)
Publication Number | Publication Date |
---|---|
NO983464D0 NO983464D0 (no) | 1998-07-28 |
NO983464L true NO983464L (no) | 1998-07-28 |
Family
ID=7784639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO983464A NO983464L (no) | 1996-01-29 | 1998-07-28 | Buffersystemer for stabilisering av farmas°ytiske preparater |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0877628A2 (no) |
JP (1) | JP2000504334A (no) |
AU (1) | AU1870497A (no) |
CA (1) | CA2244213A1 (no) |
DE (1) | DE19648650C2 (no) |
NO (1) | NO983464L (no) |
WO (1) | WO1997028104A2 (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7250153B2 (en) * | 2002-12-12 | 2007-07-31 | Biophysica Research, Inc. | Contrast media formulations having improved biological tolerance |
JP2005170923A (ja) * | 2003-10-21 | 2005-06-30 | Konica Minolta Medical & Graphic Inc | リポソーム含有x線造影剤およびその製造方法 |
JP2005170928A (ja) * | 2003-10-21 | 2005-06-30 | Konica Minolta Medical & Graphic Inc | リポソーム含有x線造影剤およびその製造方法 |
JP2005220034A (ja) * | 2004-02-03 | 2005-08-18 | Konica Minolta Medical & Graphic Inc | X線検査用造影剤の製造方法 |
JP4654590B2 (ja) * | 2004-03-31 | 2011-03-23 | コニカミノルタエムジー株式会社 | X線ct用造影組成物およびその製造方法 |
EP1772156A1 (en) * | 2004-07-21 | 2007-04-11 | Konica Minolta Medical & Graphic, Inc. | Liposome-containing x-ray radiopaque dye and process for producing the same |
CN102802671B (zh) * | 2010-03-23 | 2015-07-22 | 通用电气医疗集团股份有限公司 | 稳定的x射线诊断组合物的制备 |
WO2014025042A1 (ja) | 2012-08-10 | 2014-02-13 | 大鵬薬品工業株式会社 | 安定なオキサリプラチン封入リポソーム水分散液及びその安定化方法 |
DK3021859T3 (en) | 2013-10-25 | 2018-03-05 | Psioxus Therapeutics Ltd | ONCOLYTIC ADENOVIRA EQUIPPED WITH HETEROLOGICAL GENES |
JP7064437B2 (ja) | 2015-12-17 | 2022-05-10 | サイオクサス セラピューティクス リミテッド | 抗tcr複合体抗体又は断片をコードするb群アデノウイルス |
WO2018041827A1 (en) | 2016-08-29 | 2018-03-08 | Psioxus Therapeutics Limited | Adenovirus armed with bispecific t cell engager (bite) |
JP6867639B2 (ja) * | 2016-10-11 | 2021-05-12 | 学校法人 聖マリアンナ医科大学 | 非イオン性ヨード造影剤の結合体 |
GB201801614D0 (en) * | 2018-01-31 | 2018-03-14 | Psioxus Therapeutics Ltd | Formulation |
EP4011369A1 (en) | 2020-12-14 | 2022-06-15 | G.L. Pharma GmbH | Aqueous pharmaceutical composition comprising tapentadol tartrate |
JP7353453B1 (ja) | 2022-10-31 | 2023-09-29 | キユーピー株式会社 | エマルジョン、及びその製造方法 |
JP7372429B1 (ja) | 2022-10-31 | 2023-10-31 | キユーピー株式会社 | エマルジョン、及びその製造方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4278654A (en) * | 1978-07-04 | 1981-07-14 | Nyegaard & Co. A/S | Process for the preparation of a sterile injectable physiologically acceptable solution of an X-ray contrast agent and solutions of the X-ray contrast agent and a buffer |
GB9020091D0 (en) * | 1990-09-14 | 1990-10-24 | Nycomed As | Contrast media |
DE4121568C2 (de) * | 1991-04-22 | 1997-07-03 | Schering Ag | Verfahren und Vorrichtung zur Herstellung eines Kontrastmediums aus einem Konzentrat |
IT1256248B (it) * | 1992-12-24 | 1995-11-29 | Bracco Spa | Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x |
-
1996
- 1996-11-15 DE DE19648650A patent/DE19648650C2/de not_active Expired - Fee Related
- 1996-12-20 CA CA002244213A patent/CA2244213A1/en not_active Abandoned
- 1996-12-20 EP EP96946112A patent/EP0877628A2/de not_active Withdrawn
- 1996-12-20 AU AU18704/97A patent/AU1870497A/en not_active Abandoned
- 1996-12-20 JP JP9527225A patent/JP2000504334A/ja active Pending
- 1996-12-20 WO PCT/DE1996/002488 patent/WO1997028104A2/de not_active Application Discontinuation
-
1998
- 1998-07-28 NO NO983464A patent/NO983464L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1997028104A3 (de) | 1997-09-12 |
NO983464D0 (no) | 1998-07-28 |
EP0877628A2 (de) | 1998-11-18 |
DE19648650C2 (de) | 1998-07-02 |
CA2244213A1 (en) | 1997-08-07 |
WO1997028104A8 (de) | 1997-12-18 |
AU1870497A (en) | 1997-08-22 |
DE19648650A1 (de) | 1997-08-07 |
JP2000504334A (ja) | 2000-04-11 |
WO1997028104A2 (de) | 1997-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO983464L (no) | Buffersystemer for stabilisering av farmas°ytiske preparater | |
BG60102B2 (bg) | Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол | |
NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
YU84703A (sh) | Oralni rastvor aripiprazola | |
NO943888L (no) | Farmasöytisk preparat | |
EE04911B1 (et) | Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks | |
HUP0004383A2 (hu) | Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény | |
ITFI930247A1 (it) | Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche. | |
IS4345A (is) | Setin N-(indól-2-karbónýl)-b-alaninamíð, notkun þeirra og lyfjaefnablöndur | |
SE8602723D0 (sv) | Thiazoles, their production and pharmaceutical compositions containing them | |
ATE260658T1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
NO883229D0 (no) | Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater. | |
DK72289D0 (da) | Cephemcarboxylsyreestere, deres fremstilling og anvendelse | |
ATE470434T1 (de) | Thimerosal-freie konservierungsmittel für impfstoffe | |
ATE253359T1 (de) | Antithrombotische mittel | |
ATE286395T1 (de) | Antithrombotische mittel | |
DE60029979D1 (de) | LIPOSOMZUSAMMENSETZUNG VON 6,9-BIS-i(2-AMINOETHYL)-AMINOöBENZOiGöISOQUINOLIN-5,10-DIONE-DIMALEAT | |
NO920050L (no) | Trifluormetyl-1-karba(1-detia)cefemer | |
NO972605L (no) | Ny fremgangsmåte for fremstilling av ranitidin | |
NO975526D0 (no) | Nye laksativpreparater og fremgangsmåte for fremstilling av slike | |
IS3947A (is) | Amínósýru afleiður, aðferð til framleiðslu þeirraog notkunar sem lyfja | |
TR200402685T4 (tr) | Merkezi sinir sistemi üzerine etki eden siklobüta-indol karboksamid türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler. | |
NO20002944L (no) | FremgangsmÕte for fremstilling av isopropylmetyl-(2-)3-n- propolsyfenoksy)etyl)amin | |
DE50212538D1 (de) | Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzoäcüfluoren-6-carbonsäurederivate als nmda-antagonisten | |
DE69824410D1 (en) | Antithrombosemittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |